GH axis research
Work comparing modified and unmodified GRF analogues, where the DAC and the counter-ion are both variables under study rather than details.
Peptide · Growth hormone axis
The drug-affinity-complex form of CJC-1295 — a different molecule from the plain peptide, with a different counter-ion, and the product whose documentation is most often mixed up in this catalogue.
Also known as CJC-1295 DAC · CJC-1295 · GRF(1-29) with DAC · DAC:GRF
Overview
CJC-1295 with DAC is a GRF(1-29) analogue carrying a maleimidopropionic acid drug-affinity complex. The DAC is the point of the molecule: it is what the “with DAC” in the name refers to, and it is why this product is not interchangeable with the CJC-1295 listed a few lines below it in our catalogue.
The two differ in mass, in counter-ion and in how they are handled. Our batch of the DAC form is the trifluoroacetate salt, with 18.3% TFA and a peptide content of 84.5%. The non-DAC product is a different specification entirely. If a quotation is headed “CJC-1295” without saying which of the two it is, the quote is ambiguous and should be treated that way.
We publish this page without a CAS number, molecular formula or sequence, because the certificate for the batch we hold does not print them. Those values are available with the quotation, and we would rather leave a field empty than fill it from memory — a CAS number that cannot be tied to a document is worse than no number at all.
Identity
The identifiers your specification sheet, customs paperwork and product label all have to agree on. Where a number depends on the salt form, both are given.
HS codes are indicative only. Final classification is confirmed per shipment with your customs broker.
Manufacture
The peptide is the easy half. Attaching the DAC and removing the trifluoroacetate are the steps that decide what you receive.
The GRF(1-29) backbone is assembled on resin, then modified to carry the maleimidopropionic acid linker that defines the DAC form.
The DAC is attached through the linker. Incomplete conjugation leaves unmodified peptide in the batch — a closely related impurity that purification has to resolve.
Reversed-phase HPLC against the conjugated product. The largest single impurity of 0.4% on this lot reflects how much unconjugated material survived.
The peptide is supplied as the trifluoroacetate. TFA is a strong ion-pairing acid that improves chromatography and solubility; it is also the reason this product cannot be treated as interchangeable with an acetate form.
Applications
Supplied to laboratories studying the growth-hormone axis with an extended-half-life analogue. Research use only.
Work comparing modified and unmodified GRF analogues, where the DAC and the counter-ion are both variables under study rather than details.
The DAC form is used where the conjugation chemistry itself is the subject, since the linker is what changes the pharmacokinetic behaviour.
A useful case for methods that must distinguish conjugated from unconjugated peptide — the impurity that matters here is a near-neighbour, not a truncation.
Specification
The written limits we release against, with the method used to test each one. Batch results for the lot you receive are stated on its certificate of analysis.
| Parameter | Limit | Method |
|---|---|---|
| Appearance | White or almost white powder | Visual |
| Solubility | Soluble in water | Visual |
| Water content | ≤ 8.0% | Karl Fischer |
| Acetic acid | ≤ 0.25% | HPLC |
| Trifluoroacetic acid | ≤ 25.0% | HPLC |
| Purity | ≥ 98.0% | HPLC |
| Peptide content (N) | ≥ 80.0% | Nitrogen determination |
| Largest single impurity | ≤ 1.0% | HPLC |
| Bacterial endotoxin | < 10 EU/mg | LAL |
| Shelf life | 24 months from manufacture | Stability programme |
Tighter limits — for example a lower heavy-metal ceiling or a residual-solvent panel — can be quoted against your own specification wording.
Certificate
This is the product where a certificate most often describes the wrong molecule, because the catalogue names are too similar.
ED0003 is the DAC form; ES005 is CJC-1295 without DAC. They have different masses, different counter-ions and different specifications. A certificate headed with the name alone cannot be matched to an order.
A high trifluoroacetate load lowers peptide content and introduces an acid that is not inert in every assay. If your protocol is sensitive to residual TFA, this is a specification to discuss before ordering rather than after.
The purity figure describes the peptide fraction of the organic material; the peptide content describes how much of the powder is peptide. With 18.3% TFA and 3.9% water, a 10 mg weighing holds about 8.5 mg of peptide.
Documentation & packaging
The paperwork travels with the goods. If your QA team needs an extra declaration, ask before the order is released — some are issued per production lot and cannot be retrofitted.
Purity, TFA content, water, peptide content, largest single impurity and endotoxin for the lot supplied.
The enterprise standard the batch is released against, including the TFA limit.
Mass spectrometry data, and the CAS number and molecular formula on request where the batch certificate does not print them.
Issued on request — this product does not currently ship with a safety data sheet in the pack.
| Pack size | Presentation | Typical use |
|---|---|---|
| 1–10 g | Amber vial, 10 mL | Evaluation |
| 25–50 g | Amber vial, 50 mL | Pilot scale |
| 100 g | Amber vial, 100 mL | Small commercial |
| 1 kg+ | Foil bag, quoted per order | Bulk |
Questions
The questions buyers actually ask about CJC-1295 with DAC. Anything not covered here, ask directly — you will get an answer from someone technical, not a template.
Related
Quotation
Send the quantity, the grade you need and the destination. You will get a written quotation with lead time, packaging options and the documentation set for this material.